Overview

A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Status:
Recruiting

Trial end date:
2022-07-31

Target enrollment:

Participant gender:

Summary

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsule plus high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).

Phase:

Phase 2

Details

Lead Sponsor:

Shandong University

Treatments:

Dexamethasone
Glycyrrhizic Acid